Daniel S Longyhore received his Doctor of Pharmacy Degree from Wilkes University and completed post-graduate residency training at Palmetto Health Richland in Columbia, South Carolina and the St. Louis College of Pharmacy/Mercy Family Medicine in St. Louis, Missouri. He is currently an Associate Professor in the Department of Pharmacy Practice and the Director of the Pharmacy Preceptor and Learning Program. Dr. Longyhore has earned his Master's Degree in Education and is currently pursuing a Doctorate in Educational Leadership. He is an active member of the American College of Clinical Pharmacy (ACCP) and faculty member with their Teaching and Learning Academy. His education interests include performance-based assessment, curriculum design & assessment, and instructional design.
Dr. Longyhore is Board Certified in Ambulatory Care Pharmacy (BCACP) and serves as the ambulatory care preceptor for the PGY1 pharmacy residency at St. Luke’s University Hospital. He is a member of the iForumRx editorial advisory board and chair-elect for 2020 Eastern States Conference for Pharmacy Residents and Preceptors. His practice interests include disorders of the endocrine system (osteoporosis, diabetes), behavior-change counseling and shared-decision making, and implementing strategies for evidence-based practice at the point-of-care.
Pharmacy Care Lab series
Longyhore DS, Dixon DL, Noel ZR. When to Say When: A modified approach to setting boundaries for content in pharmacy school. Accepted Am J Pharm Educ.
Longyhore DS, Williams S. Clinical response to insulin R U-500 based on total daily insulin dose prior to conversion from U-100 insulin concentrations. American Pharmacists Association, Nashville, Tennessee, March 2018
Franko T, Longyhore D. (letter) Naloxone coverage remains a barrier to use. J Am Pharm Assoc 2017;Nov - Dec;57(6):740. doi: 10.1016/j.japh.2017.05.017
Longyhore DS. Pharmacy student anxiety and success with objective structured clinical examinations (OSCEs). Am J Pharm Educ 2017; 81(1): Article 7.
Williams S, Longyhore DS. Comparing regimens of insulin glargine U-300 plus lispro U-100 or lispro U-200 in patients converted from U-100 basal insulins. American Society of Health-System Pharmacy, Orlando, Florida, December 2017
Longyhore DS, Williams S. Comparing regimens of insulin R U-500 to glargine U-300 plus lispro (U-100 or U-200) in patients requiring conversion to concentrated insulin. American College of Clinical Pharmacy, Phoenix, Arizona, October 2017
Longyhore DS, Johnson LA. Evaluating the Accuracy of Several Different Methods for Estimating Renal Function for the Purpose of Dosing Medications. American College of Clinical Pharmacy Global Conference on Clinical Pharmacy. San Francisco, California. October 2015.
Longyhore DS, Ren YL, Menak R. Using In-Hospital COPD Inhaled-Medication Regimens as Predictors for Subsequent Hospital Admissions. American College of Clinical Pharmacy Global Conference onClinical Pharmacy. San Francisco, California. October 2015.
|Service, Honors, Awards||
Chair-elect, 2020 Eastern States Conference for Pharmacy Residents and Preceptors
Editorial Advisory Board, iForumRx.org